Actively Recruiting
HUmanitas PROtontherapy (HU-PRO)
Led by Istituto Clinico Humanitas · Updated on 2026-01-21
500
Participants Needed
1
Research Sites
520 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Proton therapy is a cancer treatment, similar to the more commonly used radiation therapy. It uses radiation to destroy cancer cells and helps control the disease in the treated area. However, when proton therapy is compared with standard radiation therapy, many studies show fewer side effects and better disease control. This is due to the unique physical properties of the particles used in proton therapy. At present, in Italy, this innovative treatment is available only for selected diseases, as defined by national guidelines. For this reason, it is very important to collect as much data as possible to support the further development of proton therapy and to improve treatment safety and effectiveness.
CONDITIONS
Official Title
HUmanitas PROtontherapy (HU-PRO)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Solid tumors candidate to proton therapy, in particular, according to Italian regolamentations
- Written informed consent for HU-PRO according to applicable legal and ethical requirements
- Indication for proton therapy
- 18 years old or older
- ECOG PS (performance status scale) 0-2
You will not qualify if you...
- Younger than 18 years old
- ECOG performance status scale greater than 3
- Life expectancy less than 3 months
- Unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Humanitas Research Hospital
Rozzano, Michigan, Italy, 20025
Actively Recruiting
Research Team
M
Marta Scorsetti, MD, radiation oncologist
CONTACT
D
Davide Franceschini, MD, radiation oncologist
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here